TAKEDA PHARMACEUTICAL CO LTD (TAK, TKPHF) — 13F holdings

TAKEDA PHARMACEUTICAL CO LTD (TAK, TKPHF) reported 9 holdings worth $16.4M in its 13F filing for Q3 2025, filed November 13, 2025.

Largest positions

1. OVID OVID THERAPEUTICS INC — $9.79M (59.8%)
2. EQ EQUILLIUM INC — $2.61M (15.9%)
3. XILIO THERAPEUTICS INC — $1.24M (7.6%)
4. STTK SHATTUCK LABS INC — $1.23M (7.5%)
5. LYELL IMMUNOPHARMA INC — $891K (5.4%)
6. AMWL AMERICAN WELL CORP — $478K (2.9%)
7. RANI RANI THERAPEUTICS HLDGS INC — $102K (0.6%)
8. LAB Standard BioTools Inc — $21.5K (0.1%)